Mygene Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Series C
- Investors
-
7
Mygene General Information
Description
Developer of a gene detection technology. The company specializes in the research and development, production, promotion and sales of molecular diagnostic products and uses medical bioinformatics and sequencing technology to provide tumor genetic susceptibility prediction, early screening, companion diagnosis and prognosis monitoring services, enabling clients to efficiently improve medical precision.
Contact Information
Website
www.maijinggene.comCorporate Office
- Unit C101, No. 9 Luoxuan 4th Road
- International Biological Island
- Guangzhou, Guangdong
- China
Corporate Office
- Unit C101, No. 9 Luoxuan 4th Road
- International Biological Island
- Guangzhou, Guangdong
- China
Mygene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 29-Dec-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 29-Dec-2019 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 18-Apr-2018 | Completed | Generating Revenue |
Mygene Comparisons
Industry
Financing
Details
Mygene Competitors (1)
One of Mygene’s competitors is GeneCast Biotechnology, a Private Equity-Backed company based in Wuxi, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GeneCast Biotechnology | Private Equity-Backed | Wuxi, China |
Mygene Patents
Mygene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2008018859-A2 | Diagnostic kit for determining genotypes of a human papilloma virus and method of using thereof | Inactive | 05-Aug-2005 | ||
| WO-2008018859-A3 | Diagnostic kit for determining genotypes of a human papilloma virus and method of using thereof | Inactive | 05-Aug-2005 | ||
| US-20070031826-A1 | Diagnostic kit for determining the genotype of a human papilloma virus and method of using thereof | Inactive | 05-Aug-2005 | C12Q1/708 |
Mygene Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Harris Fraser Group | Corporation | Minority | ||
| Jiuyou Capital | Venture Capital | Minority | ||
| Shenzhen Yifeng Investment Management Enterprise | Venture Capital | Minority | ||
| CASH Capital | Venture Capital | Minority | ||
| Fujian Zhanglong Sanjun Venture Investment | Growth/Expansion | Minority |
Mygene FAQs
-
When was Mygene founded?
Mygene was founded in 2015.
-
Where is Mygene headquartered?
Mygene is headquartered in Guangzhou, China.
-
What industry is Mygene in?
Mygene’s primary industry is Decision/Risk Analysis.
-
Is Mygene a private or public company?
Mygene is a Private company.
-
What is Mygene’s current revenue?
The current revenue for Mygene is .
-
How much funding has Mygene raised over time?
Mygene has raised $14.2M.
-
Who are Mygene’s investors?
Harris Fraser Group, Jiuyou Capital, Shenzhen Yifeng Investment Management Enterprise, CASH Capital, and Fujian Zhanglong Sanjun Venture Investment are 5 of 7 investors who have invested in Mygene.
-
Who are Mygene’s competitors?
GeneCast Biotechnology is a competitor of Mygene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process